Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

CRG's Third Healthcare Fund Closes $355 Million Term Loan Securitization

Posted on: 31 Jul 17

HOUSTON, July 31, 2017 /PRNewswire/ -- CRG, a premier healthcare-focused investment firm, today announced the closing of a $355 million term loan securitization on behalf of CRG Partners III, L.P. and certain of its parallel investment vehicles. The transaction was completed on July 27, 2017.

The securitization transaction – or Asset-Backed Securities financing – is the second securitization completed by CRG and represents the latest milestone in CRG's ability to deliver pioneering growth capital financing solutions to the global healthcare market. The financing consists of $355 million of notes that were sold through a private placement offering. The financing was oversubscribed and the notes were purchased by a broad syndicate of sophisticated institutional investors.

Mike Weinmann, CRG Managing Director, commented, "This transaction strengthens our ability to offer attractive long-term financing solutions to our business partners and underscores CRG's access to the capital markets. Notably, the financing was completed at more favorable pricing and terms, and raised more than twice the proceeds as our inaugural financing last year. The transaction further differentiates CRG from its competitors as a proven healthcare investor and improves our cost of capital advantage to continue meeting the demand for raising growth capital."

Goldman, Sachs & Co. LLC acted as exclusive placement agent.

About CRG

CRG is a premier healthcare-focused investment firm with more than $3.0 billion of assets under management across more than 45 portfolio companies.  The firm seeks to commit between $20 to $300 million in each company and invests across the healthcare spectrum, including: medical devices, biopharmaceuticals, tools & diagnostics, services and information technology. CRG provides growth capital in the form of long-term debt and equity to support innovative, commercial-stage healthcare companies that address large, unmet medical needs.  The firm partners with public and private companies to provide flexible financing solutions and world-class support to achieve exceptional growth objectives with minimal dilution. CRG maintains offices in Houston, Boulder, and New York. For more information, please visit

Company Contact:
Mike Weinmann, Managing Director
(212) 716-0011

Media Contact:
Nick Rust
(212) 279-3115 ext. 252

Editor's Details

Mike Wood

Last updated on: 31/07/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.